Company registration number 16440340 (England and Wales)
UK SURGICAL SERVICES GROUP LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
UK SURGICAL SERVICES GROUP LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
UK SURGICAL SERVICES GROUP LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2025
31 December 2025
- 1 -
2025
Notes
£
£
Fixed assets
Investments
3
127
Current assets
Cash at bank and in hand
127
Net current assets
127
Net assets
254
Capital and reserves
Called up share capital
4
254
The notes on pages 2 to 4 form part of these financial statements.
For the financial period ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 30 September 2026 and are signed on its behalf by:
H Ashour
Director
Company registration number 16440340 (England and Wales)
UK SURGICAL SERVICES GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information
UK Surgical Services Group Limited is a private company limited by shares incorporated in England and Wales. The registered office is RMT Accountants & Business Advisors Ltd, Gosforth Park Avenue, Newcastle upon Tyne, NE12 8EG.
1.1
Reporting period
The company was incorporated on 9 May 2025 and these financial statements cover the period from incorporation to 31 December 2025.
The shortened first accounting period has been adopted to align the company's accounting reference date with that of its subsidiary undertakings. No comparative information is presented as these are the company's first financial statements.
1.2
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.
1.3
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.4
Fixed asset investments
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
1.5
Cash and cash equivalents
Cash and cash equivalents comprise cash held at bank.
1.6
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
UK SURGICAL SERVICES GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 3 -
Basic financial assets
Basic financial assets, including cash at bank, are initially recognised at transaction price and subsequently measured at amortised cost using the effective interest method.
Financial assets are assessed for indicators of impairment at each reporting date.
Basic financial liabilities
Financial liabilities are initially recognised at transaction price and subsequently measured at amortised cost using the effective interest method.
2
Employees
The average monthly number of persons (including directors) employed by the company during the period was:
2025
Number
Total
2
3
Fixed asset investments
2025
£
Shares in group undertakings and participating interests
127
Movements in fixed asset investments
Shares in subsidiaries
£
Cost or valuation
At 9 May 2025
-
Additions
127
At 31 December 2025
127
Carrying amount
At 31 December 2025
127
4
Called up share capital
2025
2025
Ordinary share capital
Number
£
Issued and fully paid
Ordinary shares of £1 each
254
254
UK SURGICAL SERVICES GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2025
4
Called up share capital
(Continued)
- 4 -
On incorporation, 127 ordinary shares of £1 each were issued and fully paid.
On 16 December 2025, a further 127 ordinary shares of £1 each were issued in consideration for the acquisition of the entire issued share capital of Tyneside Surgical Services Limited by way of a share-for-share exchange.